ReachRxResearch
Home
Research
Sign Up
METTL3 destabilizes RFX7 to ameliorate PDGF-BB-induced airway smooth muscle cell dysfunction and inflammation in an in vitro model of childhood asthma
Back to Research Hub
  1. Home
  2. Research Hub
  3. METTL3 destabilizes RFX7 to ameliorate P…

METTL3 destabilizes RFX7 to ameliorate PDGF-BB-induced airway smooth muscle cell dysfunction and inflammation in an in vitro model of childhood asthma

Journal of Asthma·October 20
AllergyLimited evidenceChildhood AsthmaIn Vitro StudyRNA MethyltransferasePediatricRegranexBecaplermin

Summary

View source

What was studied

This in vitro study examined the role of the METTL3–RFX7 axis in PDGF-BB-stimulated airway smooth muscle cells (ASMCs) as a model of childhood asthma, assessing effects on cell proliferation, migration, invasion, inflammation (IL-6, TNF-α), oxidative stress (ROS, MDA), and macrophage polarization.

Key findings

RFX7 was elevated in pediatric asthma patient serum and in PDGF-BB-stimulated ASMCs, while METTL3 was downregulated; RFX7 knockdown and METTL3 overexpression each attenuated ASMC proliferation, migration, invasion, IL-6/TNF-α production, ROS/MDA levels, and CD86+ macrophage proportion, with METTL3 acting via YTHDF2-dependent destabilization of RFX7 transcripts.

Study limitations

All functional experiments were conducted in vitro only, with no animal or clinical validation; the study does not report sample sizes for patient serum cohorts or effect sizes with confidence intervals; causal directionality in human disease cannot be established from cell-line data.

Clinical implications

This is early-stage mechanistic research; the METTL3–RFX7 axis is not yet ready for clinical application, but it may inform future therapeutic targets for airway remodeling in childhood asthma.

Caveats

  • All mechanistic findings derive exclusively from cell culture experiments (PDGF-BB-stimulated ASMCs); no animal models or clinical intervention data are presented, severely limiting translational relevance
  • Patient serum data are correlational only; sample size and demographic details for the pediatric asthma cohort are not reported in the abstract or results
  • PDGF-BB is used as a pharmacological stimulus to model asthma, which may not fully recapitulate the complex in vivo pathophysiology of childhood asthma

Related Questions

Explore related topics

METTL3 m6A modification in asthma airway remodelingRFX7 transcription factor role in inflammation and smooth muscle cellsPDGF-BB airway smooth muscle cell proliferation and migration in asthma

Publication Details

Year
2026
Journal
Journal of Asthma
Source
View article
Keep scrolling
More content below.
Up Next